Stock Analysis

Baowu Magnesium Technology And 2 Other Growth Stocks With Strong Insider Ownership

TSE:186A
Source: Shutterstock

As global markets show signs of optimism with cooling inflation and strong bank earnings propelling stocks higher, investors are increasingly focusing on growth companies that demonstrate resilience in fluctuating economic conditions. A key indicator of potential success in such firms is high insider ownership, which often signals confidence from those closest to the company's operations and strategy.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
SKS Technologies Group (ASX:SKS)29.7%24.8%
Propel Holdings (TSX:PRL)36.8%38.9%
Waystream Holding (OM:WAYS)11.3%113.3%
Medley (TSE:4480)34.1%27.2%
Pharma Mar (BME:PHM)11.9%55.1%
Kingstone Companies (NasdaqCM:KINS)20.8%24.9%
Brightstar Resources (ASX:BTR)16.2%84.1%
Plenti Group (ASX:PLT)12.7%120.1%
Fine M-TecLTD (KOSDAQ:A441270)17.2%135%
Elliptic Laboratories (OB:ELABS)26.8%121.1%

Click here to see the full list of 1462 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Baowu Magnesium Technology (SZSE:002182)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Baowu Magnesium Technology Co., Ltd. is involved in mining and non-ferrous metal smelting and processing both in China and internationally, with a market cap of CN¥11.34 billion.

Operations: The company generates revenue primarily through its Non-Ferrous Metal Smelting and Rolling Processing segment, which accounts for CN¥8.15 billion.

Insider Ownership: 17%

Earnings Growth Forecast: 61.5% p.a.

Baowu Magnesium Technology is positioned for substantial growth, with revenue expected to increase by 25.2% annually, outpacing the broader Chinese market. Despite a decline in net income to CNY 153.76 million for the first nine months of 2024, earnings are forecasted to grow significantly at 61.5% per year over the next three years. However, concerns include low return on equity projections and insufficient debt coverage by operating cash flow, alongside a dividend yield not well supported by free cash flows.

SZSE:002182 Ownership Breakdown as at Jan 2025
SZSE:002182 Ownership Breakdown as at Jan 2025

PharmaResources (Shanghai) (SZSE:301230)

Simply Wall St Growth Rating: ★★★★★☆

Overview: PharmaResources (Shanghai) Co., Ltd. operates as a CRO, CDMO, and CMO service provider in drug discovery in China with a market cap of CN¥3.38 billion.

Operations: PharmaResources (Shanghai) Co., Ltd. generates revenue through its roles as a CRO, CDMO, and CMO service provider in the Chinese drug discovery sector.

Insider Ownership: 13.9%

Earnings Growth Forecast: 50.8% p.a.

PharmaResources (Shanghai) is expected to experience strong growth, with earnings projected to increase by 50.8% annually, surpassing the broader Chinese market's growth rate. Despite a recent decline in net profit margins from 14.6% to 1.3%, revenue is forecasted to grow at 20.9% per year. The company recently completed a share buyback of CNY 53.08 million, representing 1.47% of shares, but faces challenges with low return on equity and unsustainable dividend coverage.

SZSE:301230 Earnings and Revenue Growth as at Jan 2025
SZSE:301230 Earnings and Revenue Growth as at Jan 2025

Astroscale Holdings (TSE:186A)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Astroscale Holdings Inc. offers on-orbit service solutions and has a market capitalization of ¥76.48 billion.

Operations: The company's revenue is primarily derived from its In-Orbit Servicing Business, which generated ¥2.35 billion.

Insider Ownership: 21.3%

Earnings Growth Forecast: 76.6% p.a.

Astroscale Holdings is forecast to see robust revenue growth of 42.5% annually, outpacing the Japanese market's average. However, its Return on Equity is projected to remain modest at 17.1% in three years. The company recently joined the S&P Global BMI Index and announced an ambitious ADRAS-J mission milestone, enhancing its space debris removal capabilities despite facing operational challenges. Financial forecasts indicate significant losses for FY2025 with revenue expected at ¥8 billion (US$0.05 billion).

TSE:186A Ownership Breakdown as at Jan 2025
TSE:186A Ownership Breakdown as at Jan 2025

Where To Now?

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com